It remains, however, that all these measures do not reflect any sample size and thus making it sometimes difficult to assess with confidence the true performance of these diagnosis models, in particular for small sample size. In this paper, we propose to use systematically, a ROC-based methodology that makes possible to calculate the Confidence Interval (CI) at each ROC point. The methodology is generic and robust to sample size, and based on Probability Density Function (PDF) without any assumption on the distribution. We illustrate its use on 6 recent studies and show that results with the additional AUC 95% CI contour is more adequate to compare the performance of these diagnosis models, especially with studies using different sample size.
I. INTRODUCTION
Numerous studies, in the gynecology literature, provide performance of diagnosis models such as univariate models, Risk of Malignancy Index (RMI) [1] [2] and Logistic Regression (LR) [3] [4] . Performance results are typically presented as sensitivity (SEN), specificity (SPE), accuracy (ACC), Positive Predictive Value (PPV), Negative Predictive Value (NPV). Some studies include additional Receiver Operating Characteristic (ROC) analysis with a ROC curve, calculation of the Area Under the Curve (AUC) [5] and Standard Error (SE) [6] . It remains, however, that all these measure do not reflect any sample size and thus making it difficult to assess with confidence the true performance of the models and diagnosis. A methodology that would take into account sample size would also be very useful when comparing results from studies with different sample size.
In this paper we introduce a methodology originally developed by Tilbury [7] that allow to calculate, at a defined level of confidence (typically 0.05 for 95%), the Confidence Interval (CI) contour for each point of the ROC curve. We illustrate its use with recent studies taken from the gynecology literature presented by Yamamoto [8] , Manjunath [9] , Ma [10] , Obeidat [2] , Ulusoy [11] , and Aslam [12] .
The rest of the paper is organized as follow. In Section II we formulate the problem. The most commonly used diagnosis models in gynecology are presented in Section III. In Section IV we illustrate the novel approach with results from recent studies in gynecology. Finally, we conclude the paper in Section V.
II. PROBLEM FORMULATION
Let us consider the following typical scenario. The outcome of a classifier for a 2-class medical diagnosis (benign or malignant, i.e. from the Ground Truth) can be of four types: True Positive (TP) when the tumor is malignant and diagnosed correctly, True Negative (TN) when the tumor is benign and diagnosed correctly, False Positive (FP) when the tumor is benign but diagnosed incorrectly as malignant, and False Negative (FN) when the tumor is malignant but diagnosed incorrectly as benign. These are shown in Table I . We know that the sample size of each groups is nBen=TN+FP and nMal=TP+FN. Using these counts, one can calculate he sensitivity and specificity performance measures, typically published in the literature together with sample size of the benign (nBen) and malignant (nMal) groups. As a reminder, sensitivity and specificity are defined as + and + , respectively. As useful and informative these performance measure can be to the clinical gynecologist, they lack any sense/dimension of sample size. A sensitivity of 80% could be from different ratios with different sample sizes. Measures such as Positive Predictive Value (PPV) and Negative Predictive Value (NPV) are use in gynecology research and also suffer from the same sample issue issue. There is thus a need to provide confidence Interval (CI) (e.g. 95%CI), for each point of the ROC curve, that will allow for e.g. to compare results from studies with different sample size.
Tilbury [7] proposed a ROC-based methodology for performance evaluation of intelligent medical systems as a Bayesian approach to the AUC CI calculation, which was shown particularly suitable for small sample size (more details in [13] ). WE use a fast computation formulation for calculating the lower and upper bounds of AUC CIs, recently proposed in [14] .
III. DIAGNOSIS MODELS
The most common diagnosis models in ovarian cancer research include univariate, Risk of Malignancy Index (RMI) and Logistic Regression (LR). Univariate models take a single variable such as post-menopause score, ultrasound score, serum CA125 level as unique feature and a diagnosis decision is taken by a threshold. Risk of Malignancy Index (RMI), first introduced by Jacobs [16] , combines variables as follow:
where M post-menopause score (M = 1 when patient is premenopause and M = 3 when patient is post-menopause), U is the ultrasound score (typically a total ultrasound score of 0 or 1 yielded U = 1, and a score of ≥2 yielded U = 4 [17] ) and CA125 is a direct measure, typically in ml, of the level of CA125 serum. The RMI model, simple in its calculation and interpretation, has been the subject of numerous studies [18] [17] [19] [1]. In recent years, Logistic Regression (LR) models have gained popularity in gynecology [20] [21] . It aims to predict an outcome from multiple variables, using a form as:
where the number of variables, X is set of variables, and 0 ... are the regression coefficients estimated using maximum-likelihood and the least-squares regression fitting procedures. 
IV. RESULTS FROM RECENT STUDIES
We re-examined the results from few recent studies using our approach. For each model of each study, the sensitivity and specificity are summarized in Table II . Using our approach we calculate AUC at the ROC point and AUC-L, the 95% CI AUC lower bound. We also indicate the sample size in each group, with number of benign (nBen) and malignant (nMal) cases.
ROC curves for each models in each study are used to assess the 95% CI contour. ROC curve with 95% CI contours are plotted for each model. Results from the Yamamoto's study [8] are presented in Figure 1 , results from the Manjunath's study [9] are shown in Figure 2 , from Ma's study [10] in Figure 3 , those of Obeidat's study [2] in Figure 4 , of Ulusoy's study [11] in Figure 5 , and finally, results from the Aslam's study [12] are shown in Figure 6 . Due to the different performance and differences in sample size (both in terms of total number but also different ratio between benign and malignant), the 95% CI contours are large 
V. CONCLUSIONS
In this paper, we presented a novel approach to visualize the performance of medical diagnosis models that overcome the issue of different sample size. It is recognized that as performance evaluation is typical claimed in terms of the sensitivity and specificity, and that, however, the sample size is rarely taken into consideration. Using the CI contour at the ROC, the methodology provide adequate visual indication as true performance (using the lower bound of the CI contour). We illustrated the methodology with the re-examination of the results from recently published studies which compared the performance of univariate, RMI and LR models for the diagnosis of ovarian cancer. Using the ROC with CI contour, one can assess the true performance of these diagnosis models, and furthermore, can assess any overlap of the CI contour with chance line and compare models all together considering that the difference in sample size is taken into account by the CI contour calculation.
Finally, it should be reminded that only the use of larger data set, such as the one created for the International Ovarian Tumor Analysis (IOTA) group with 1066 (800 benign and 266 malignant) patients [22] , will give make the CI contour shrink and provide good confidence in the diagnosis performance. 
